Show simple item record

Association of low numbers of CD 206‐positive cells with loss of ICC in the gastric body of patients with diabetic gastroparesis

dc.contributor.authorBernard, C. E.en_US
dc.contributor.authorGibbons, S. J.en_US
dc.contributor.authorMann, I. S.en_US
dc.contributor.authorFroschauer, L.en_US
dc.contributor.authorParkman, H. P.en_US
dc.contributor.authorHarbison, S.en_US
dc.contributor.authorAbell, T. L.en_US
dc.contributor.authorSnape, W. J.en_US
dc.contributor.authorHasler, W. L.en_US
dc.contributor.authorMcCallum, R. W.en_US
dc.contributor.authorSarosiek, I.en_US
dc.contributor.authorNguyen, L. A. B.en_US
dc.contributor.authorKoch, K. L.en_US
dc.contributor.authorTonascia, J.en_US
dc.contributor.authorHamilton, F. A.en_US
dc.contributor.authorKendrick, M. L.en_US
dc.contributor.authorShen, K. R.en_US
dc.contributor.authorPasricha, P. J.en_US
dc.contributor.authorFarrugia, G.en_US
dc.date.accessioned2014-09-03T16:51:34Z
dc.date.availableWITHHELD_13_MONTHSen_US
dc.date.available2014-09-03T16:51:34Z
dc.date.issued2014-09en_US
dc.identifier.citationBernard, C. E.; Gibbons, S. J.; Mann, I. S.; Froschauer, L.; Parkman, H. P.; Harbison, S.; Abell, T. L.; Snape, W. J.; Hasler, W. L.; McCallum, R. W.; Sarosiek, I.; Nguyen, L. A. B.; Koch, K. L.; Tonascia, J.; Hamilton, F. A.; Kendrick, M. L.; Shen, K. R.; Pasricha, P. J.; Farrugia, G. (2014). "Association of low numbers of CD 206‐positive cells with loss of ICC in the gastric body of patients with diabetic gastroparesis." Neurogastroenterology & Motility 26(9): 1275-1284.en_US
dc.identifier.issn1350-1925en_US
dc.identifier.issn1365-2982en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/108285
dc.description.abstractBackground There is increasing evidence for specific cellular changes in the stomach of patients with diabetic ( DG ) and idiopathic ( IG ) gastroparesis. The most significant findings are loss of interstitial cells of Cajal ( ICC ), neuronal abnormalities, and an immune cellular infiltrate. Studies done in diabetic mice have shown a cytoprotective effect of CD 206+ M2 macrophages. To quantify overall immune cellular infiltrate, identify macrophage populations, and quantify CD 206+ and i NOS + cells. To investigate associations between cellular phenotypes and ICC . Methods Full thickness gastric body biopsies were obtained from non‐diabetic controls (C), diabetic controls ( DC ), DG , and IG patients. Sections were labeled for CD 45, CD 206, Kit, i NOS , and putative human macrophage markers ( HAM 56, CD 68, and EMR 1). Immunoreactive cells were quantified from the circular muscle layer. Key Results Significantly fewer ICC were detected in DG and IG tissues, but there were no differences in the numbers of cells immunoreactive for other markers between patient groups. There was a significant correlation between the number of CD 206+ cells and ICC in DG and DC patients, but not in C and IG and a significant correlation between i NOS + cells and ICC in the DC group, but not the other groups. CD 68 and HAM 56 reliably labeled the same cell populations, but EMR 1 labeled other cell types. Conclusions & Inferences Depletion of ICC and correlation with changes in CD 206+ cell numbers in DC and DG patients suggests that in humans, like mice, CD 206+ macrophages may play a cytoprotective role in diabetes. These findings may lead to novel therapeutic options, targeting alternatively activated macrophages. Loss of interstitial cells of Cajal and an immune cell infiltrate have been identified in the gastric smooth muscle of patients with gastroparesis. This study reports a correlation between ICC numbers and CD206‐positive, alternatively activated M2 macrophage numbers in the gastric body of patients with diabetes (Panels B, D), but not in non‐diabetic controls (A) or idiopathic gastroparesis (C). Thus, CD206‐positive macrophages may play a cytoprotective role in the stomach of diabetic patients.en_US
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherInterstitial Cells of Cajalen_US
dc.subject.otherGastroparesisen_US
dc.subject.otherMacrophagesen_US
dc.titleAssociation of low numbers of CD 206‐positive cells with loss of ICC in the gastric body of patients with diabetic gastroparesisen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/108285/1/nmo12389-sup-0001-TableS1.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/108285/2/nmo12389.pdf
dc.identifier.doi10.1111/nmo.12389en_US
dc.identifier.sourceNeurogastroenterology & Motilityen_US
dc.identifier.citedreferenceCancello R, Henegar C, Viguerie N, Taleb S, Poitou C, Rouault C, Coupaye M, Pelloux V, et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery‐induced weight loss. Diabetes 2005; 54: 2277 – 86.en_US
dc.identifier.citedreferenceFaussone‐Pellegrini MS, Grover M, Pasricha PJ, Bernard CE, Lurken MS, Smyrk TC, Parkman HP, Abell TL, et al. Ultrastructural differences between diabetic and idiopathic gastroparesis. J Cell Mol Med 2012; 16: 1573 – 81.en_US
dc.identifier.citedreferenceGrover M, Bernard CE, Pasricha PJ, Lurken MS, Faussone‐Pellegrini MS, Smyrk TC, Parkman HP, Abell TL, et al. Clinical‐histological associations in gastroparesis: results from the Gastroparesis Clinical Research Consortium. Neurogastroenterol Motil 2012; 24: 531 – 9, e249.en_US
dc.identifier.citedreferenceAustyn JM, Gordon S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 1981; 11: 805 – 15.en_US
dc.identifier.citedreferenceMikkelsen HB. Interstitial cells of Cajal, macrophages and mast cells in the gut musculature: morphology, distribution, spatial and possible functional interactions. J Cell Mol Med 2010; 14: 818 – 32.en_US
dc.identifier.citedreferenceMosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8: 958 – 69.en_US
dc.identifier.citedreferenceGordon S. Alternative activation of macrophages. Nat Rev Immunol 2003; 3: 23 – 35.en_US
dc.identifier.citedreferenceAlbina JE. On the expression of nitric oxide synthase by human macrophages. Why no NO? J Leukoc Biol 1995; 58: 643 – 9.en_US
dc.identifier.citedreferenceGross TJ, Kremens K, Powers LS, Brink B, Knutson T, Domann FE, Philibert RA, Milhem MM, et al. Epigenetic silencing of the human NOS2 gene: rethinking the role of nitric oxide in human macrophage inflammatory responses. J Immunol 2014; 192: 2326 – 38.en_US
dc.identifier.citedreferenceMicklem K, Rigney E, Cordell J, Simmons D, Stross P, Turley H, Seed B, Mason D. A human macrophage‐associated antigen (CD68) detected by six different monoclonal antibodies. Br J Haematol 1989; 73: 6 – 11.en_US
dc.identifier.citedreferenceKunisch E, Fuhrmann R, Roth A, Winter R, Lungershausen W, Kinne RW. Macrophage specificity of three anti‐CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry. Ann Rheum Dis 2004; 63: 774 – 84.en_US
dc.identifier.citedreferenceAdams CW, Poston RN. Macrophage histology in paraffin‐embedded multiple sclerosis plaques is demonstrated by the monoclonal pan‐macrophage marker HAM‐56: correlation with chronicity of the lesion. Acta Neuropathol 1990; 80: 208 – 11.en_US
dc.identifier.citedreferenceGown AM, Tsukada T, Ross R. Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol 1986; 125: 191 – 207.en_US
dc.identifier.citedreferenceHamann J, Koning N, Pouwels W, Ulfman LH, van Eijk M, Stacey M, Lin HH, Gordon S, et al. EMR1, the human homolog of F4/80, is an eosinophil‐specific receptor. Eur J Immunol 2007; 37: 2797 – 802.en_US
dc.identifier.citedreferenceKalff JC, Schwarz NT, Walgenbach KJ, Schraut WH, Bauer AJ. Leukocytes of the intestinal muscularis: their phenotype and isolation. J Leukoc Biol 1998; 63: 683 – 91.en_US
dc.identifier.citedreferenceMikkelsen HB, Rumessen JJ. Characterization of macrophage‐like cells in the external layers of human small and large intestine. Cell Tissue Res 1992; 270: 273 – 9.en_US
dc.identifier.citedreferenceKalff JC, Turler A, Schwarz NT, Schraut WH, Lee KK, Tweardy DJ, Billiar TR, Simmons RL, et al. Intra‐abdominal activation of a local inflammatory response within the human muscularis externa during laparotomy. Ann Surg 2003; 237: 301 – 15.en_US
dc.identifier.citedreferenceRugtveit J, Brandtzaeg P, Halstensen TS, Fausa O, Scott H. Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. Gut 1994; 35: 669 – 74.en_US
dc.identifier.citedreferenceHe CL, Soffer EE, Ferris CD, Walsh RM, Szurszewski JH, Farrugia G. Loss of interstitial cells of cajal and inhibitory innervation in insulin‐dependent diabetes. Gastroenterology 2001; 121: 427 – 34.en_US
dc.identifier.citedreferenceVittal H, Farrugia G, Gomez G, Pasricha PJ. Mechanisms of disease: the pathological basis of gastroparesis–a review of experimental and clinical studies. Nat Clin Pract Gastroenterol Hepatol 2007; 4: 336 – 46.en_US
dc.identifier.citedreferenceBattaglia E, Bassotti G, Bellone G, Dughera L, Serra AM, Chiusa L, Repici A, Mioli P, et al. Loss of interstitial cells of Cajal network in severe idiopathic gastroparesis. World J Gastroenterol 2006; 12: 6172 – 7.en_US
dc.identifier.citedreferenceForster J, Damjanov I, Lin Z, Sarosiek I, Wetzel P, McCallum RW. Absence of the interstitial cells of Cajal in patients with gastroparesis and correlation with clinical findings. J Gastrointest Surg 2005; 9: 102 – 8.en_US
dc.identifier.citedreferenceHarberson J, Thomas RM, Harbison SP, Parkman HP. Gastric neuromuscular pathology in gastroparesis: analysis of full‐thickness antral biopsies. Dig Dis Sci 2010; 55: 359 – 70.en_US
dc.identifier.citedreferenceIwasaki H, Kajimura M, Osawa S, Kanaoka S, Furuta T, Ikuma M, Hishida A. A deficiency of gastric interstitial cells of Cajal accompanied by decreased expression of neuronal nitric oxide synthase and substance P in patients with type 2 diabetes mellitus. J Gastroenterol 2006; 41: 1076 – 87.en_US
dc.identifier.citedreferencePasricha PJ, Pehlivanov ND, Gomez G, Vittal H, Lurken MS, Farrugia G. Changes in the gastric enteric nervous system and muscle: a case report on two patients with diabetic gastroparesis. BMC Gastroenterol 2008; 8: 21.en_US
dc.identifier.citedreferenceZarate N, Mearin F, Wang XY, Hewlett B, Huizinga JD, Malagelada JR. Severe idiopathic gastroparesis due to neuronal and interstitial cells of Cajal degeneration: pathological findings and management. Gut 2003; 52: 966 – 70.en_US
dc.identifier.citedreferenceMcKnight AJ, Macfarlane AJ, Dri P, Turley L, Willis AC, Gordon S. Molecular cloning of F4/80, a murine macrophage‐restricted cell surface glycoprotein with homology to the G‐protein‐linked transmembrane 7 hormone receptor family. J Biol Chem 1996; 271: 486 – 9.en_US
dc.identifier.citedreferenceBaud V, Chissoe SL, Viegas‐Pequignot E, Diriong S, N'Guyen VC, Roe BA, Lipinski M. EMR1, an unusual member in the family of hormone receptors with seven transmembrane segments. Genomics 1995; 26: 334 – 44.en_US
dc.identifier.citedreferenceKhazen W, M'Bika JP, Tomkiewicz C, Benelli C, Chany C, Achour A, Forest C. Expression of macrophage‐selective markers in human and rodent adipocytes. FEBS Lett 2005; 579: 5631 – 4.en_US
dc.identifier.citedreferenceGough PJ, Gordon S, Greaves DR. The use of human CD68 transcriptional regulatory sequences to direct high‐level expression of class A scavenger receptor in macrophages in vitro and in vivo. Immunology 2001; 103: 351 – 61.en_US
dc.identifier.citedreferenceFowler LJ, Maygarden SJ, Novotny DB. Human alveolar macrophage‐56 and carcinoembryonic antigen monoclonal antibodies in the differential diagnosis between primary ovarian and metastatic gastrointestinal carcinomas. Hum Pathol 1994; 25: 666 – 70.en_US
dc.identifier.citedreferenceBeranek JT. CD68 is not a macrophage‐specific antigen. Ann Rheum Dis 2005; 64: 342 – 3; author reply 3‐4.en_US
dc.identifier.citedreferenceGottfried E, Kunz‐Schughart LA, Weber A, Rehli M, Peuker A, Muller A, Kastenberger M, Brockhoff G, et al. Expression of CD68 in non‐myeloid cell types. Scand J Immunol 2008; 67: 453 – 63.en_US
dc.identifier.citedreferenceVillalta SA, Nguyen HX, Deng B, Gotoh T, Tidball JG. Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum Mol Genet 2009; 18: 482 – 96.en_US
dc.identifier.citedreferenceDenis M. Human monocytes/macrophages: NO or no NO? J Leukoc Biol 1994; 55: 682 – 4.en_US
dc.identifier.citedreferenceBaynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405 – 12.en_US
dc.identifier.citedreferenceCummings TJ, Hulette CM, Bigner SH, Riggins GJ, McLendon RE. Ham56‐immunoreactive macrophages in untreated infiltrating gliomas. Arch Pathol Lab Med 2001; 125: 637 – 41.en_US
dc.identifier.citedreferenceCamilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L. Clinical guideline: management of gastroparesis. Am J Gastroenterol 2013; 108: 18 – 37; quiz 8.en_US
dc.identifier.citedreferenceWang YR, Fisher RS, Parkman HP. Gastroparesis‐related hospitalizations in the United States: trends, characteristics, and outcomes, 1995‐2004. Am J Gastroenterol 2008; 103: 313 – 22.en_US
dc.identifier.citedreferenceJung HK, Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Szarka LA, Mullan B, Talley NJ. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology 2009; 136: 1225 – 33.en_US
dc.identifier.citedreferenceBielefeldt K. Gastroparesis: concepts, controversies, and challenges. Scientifica (Cairo) 2012; 2012: 424802.en_US
dc.identifier.citedreferenceParkman HP, Hasler WL, Fisher RS. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology 2004; 127: 1592 – 622.en_US
dc.identifier.citedreferenceHasler WL. Gastroparesis–current concepts and considerations. Medscape J Med 2008; 10: 16.en_US
dc.identifier.citedreferenceSpangeus A, Suhr O, El‐Salhy M. Diabetic state affects the innervation of gut in an animal model of human type 1 diabetes. Histol Histopathol 2000; 15: 739 – 44.en_US
dc.identifier.citedreferenceWang XY, Huizinga JD, Diamond J, Liu LW. Loss of intramuscular and submuscular interstitial cells of Cajal and associated enteric nerves is related to decreased gastric emptying in streptozotocin‐induced diabetes. Neurogastroenterol Motil 2009; 21: 1095 – e92.en_US
dc.identifier.citedreferenceOrdog T, Takayama I, Cheung WK, Ward SM, Sanders KM. Remodeling of networks of interstitial cells of Cajal in a murine model of diabetic gastroparesis. Diabetes 2000; 49: 1731 – 9.en_US
dc.identifier.citedreferenceHorvath VJ, Vittal H, Lorincz A, Chen H, Almeida‐Porada G, Redelman D, Ordog T. Reduced stem cell factor links smooth myopathy and loss of interstitial cells of cajal in murine diabetic gastroparesis. Gastroenterology 2006; 130: 759 – 70.en_US
dc.identifier.citedreferenceChoi KM, Gibbons SJ, Nguyen TV, Stoltz GJ, Lurken MS, Ordog T, Szurszewski JH, Farrugia G. Heme oxygenase‐1 protects interstitial cells of Cajal from oxidative stress and reverses diabetic gastroparesis. Gastroenterology 2008; 135: 2055 – 64, 64 e1‐2.en_US
dc.identifier.citedreferenceChoi KM, Kashyap PC, Dutta N, Stoltz GJ, Ordog T, Shea Donohue T, Bauer AJ, Linden DR, et al. CD206‐positive M2 macrophages that express heme oxygenase‐1 protect against diabetic gastroparesis in mice. Gastroenterology 2010; 138: 2399 – 409, 409 e1.en_US
dc.identifier.citedreferenceGrover M, Farrugia G, Lurken MS, Bernard CE, Faussone‐Pellegrini MS, Smyrk TC, Parkman HP, Abell TL, et al. Cellular changes in diabetic and idiopathic gastroparesis. Gastroenterology 2011; 140: 1575 – 85 e8.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.